Albireo Pharma, Inc.

MA · United States · Reporting entity ID 100001056884

Total reported 2019–2025

$8.45M

#548 of 2,960 reporting companies — 0% of all reported industry payments

$1.14M in general payments across 1,453 records, plus $7.31M in research funding across 1,720 records.

How it breaks down

General payments $1,137,386

Research funding $7,309,616

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.